Ignacio
Melero Bermejo
Catedrático de Universidad
Hospital Ramón y Cajal
Madrid, EspañaPublications in collaboration with researchers from Hospital Ramón y Cajal (6)
2024
-
Multiplex spatial analysis reveals increased CD137 expression and m-MDSC neighboring tumor cells in refractory classical Hodgkin Lymphoma
OncoImmunology, Vol. 13, Núm. 1
-
Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors
Clinical Cancer Research, Vol. 30, Núm. 8, pp. 1630-1641
2022
-
The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients
Journal of Pathology, Vol. 258, Núm. 4, pp. 426-436
2020
-
Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors
Science Translational Medicine, Vol. 12, Núm. 565
2019
-
Immune mechanisms mediating abscopal effects in radioimmunotherapy
Pharmacology and Therapeutics, Vol. 196, pp. 195-203
2017
-
Strategies to design clinical studies to identify predictive biomarkers in cancer research
Cancer Treatment Reviews, Vol. 53, pp. 79-97